Troriluzole, Placebo for BHV-4157 capsules, 100mg, 140mg, Troriluzole
BHV4157-303
Phase 3 small_molecule active
Quick answer
Troriluzole, Placebo for BHV-4157 capsules, 100mg, 140mg, Troriluzole for Obsessive Compulsive Disorder is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Obsessive Compulsive Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active